MEG3 and osteosarcoma: Huang et al. prepared the engineered exosomes cRGD-Exo-MEG3 and found that it could deliver lncRNA-MEG3 more efficiently to osteosarcoma cells both in vitro and in vivo, and have potentially therapeutic effects for osteosarcoma [112].